JASPER Intervention for Autism
(EBJ Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate JASPER, a play-based intervention designed to help children with autism improve their communication and social skills. The research will compare two groups: one where parents deliver JASPER with guidance, and another where clinicians work directly with the child. After 10 weeks, researchers will assess which approach is more effective. Children who are minimally verbal, have a confirmed autism diagnosis, and show some emerging phrases are good candidates for this study. Researchers will observe participants to see if their communication improves during the trial. As an unphased trial, this study offers families a unique opportunity to contribute to understanding effective autism interventions.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the JASPER intervention is safe for children with autism?
Research has shown that JASPER, a play-based program, is generally well-received by young children with autism. Studies have found that JASPER is safe when guided by either parents or clinicians.
In one study, children who participated in the JASPER program, whether led by a parent or a clinician, improved their social communication skills. No major negative effects were reported, indicating the program's safety.
JASPER has also been successfully used in various settings to help children with joint engagement and managing emotions. This background demonstrates that JASPER is a dependable choice for children with autism, focusing on enhancing their interaction and communication through guided play.
Overall, existing research supports JASPER as a safe and effective option for children who need these types of interventions.12345Why are researchers excited about this trial?
Researchers are excited about the JASPER intervention for autism because it emphasizes social communication skills and play development through naturalistic interactions. Unlike traditional autism therapies that often involve structured, therapist-led sessions focusing on behavior modification, JASPER integrates parents as active participants in the therapy process, empowering them to use therapeutic techniques in everyday interactions with their child. This parent-mediated approach is unique because it aims to make therapy more consistent and accessible, potentially leading to more meaningful improvements in a child's social engagement and overall development. Furthermore, the clinician-mediated JASPER sessions offer personalized, one-on-one interactions with therapists, ensuring that each child's specific needs are addressed.
What evidence suggests that JASPER is effective for autism?
Research shows that JASPER, a play-based program, can help improve social skills in children with autism. In this trial, participants will join one of two groups: parent-mediated JASPER or clinician-mediated JASPER. Studies have found that when either parents or clinicians use JASPER, children make significant progress in joint attention, improving their ability to focus on the same thing as someone else. Specifically, parent-led JASPER has enhanced children's joint attention skills, crucial for interacting with others. Clinician-led JASPER has also improved children's social communication skills. Overall, JASPER appears to be an effective way to help children with autism develop key social abilities.12467
Are You a Good Fit for This Trial?
This trial is for children aged 18 months to 5 years with Autism Spectrum Disorder who are minimally verbal or have emerging phrase speech. They must have a nonverbal mental age of at least 12 months and a confirmed diagnosis of autism.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Intervention Behavioral Testing
Administration of ADOS, MSEL, ESCS, SPA, CCX, and Vineland Adaptive Behavior Scales. ELSA-T and BOSCC sessions for test-retest reliability.
Treatment
Participants receive JASPER intervention, either clinician-mediated or parent-mediated, for 10 weeks. Monthly check-ins for responders and non-responders.
Follow-up
Participants are monitored for safety and effectiveness after treatment. T3 assessments conducted.
What Are the Treatments Tested in This Trial?
Interventions
- JASPER
JASPER is already approved in United States for the following indications:
- Autism Spectrum Disorder (ASD), specifically for improving social communication and play skills in minimally verbal children
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Simons Foundation
Collaborator